To Identify the Immunogenicity and Safety of Inavtivated Quadrivalent Influenza Virus Split Vaccine in Children Aged 3-8 Years With Two Doses and One Dose Pre-immunization
Latest Information Update: 08 May 2024
At a glance
- Drugs Influenza virus vaccine quadrivalent Shanghai Institute of Biological Products (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Wuhan Institute of Biological Products
- 31 May 2022 New trial record